Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Spruce Biosciences (SPRB) EBIT Margin (2023 - 2024)

Spruce Biosciences (SPRB) has disclosed EBIT Margin for 2 consecutive years, with 3453.95% as the latest value for Q4 2024.

  • Quarterly EBIT Margin fell 306898.0% to 3453.95% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 7100.0% through Sep 2025, down 649114.0% year-over-year, with the annual reading at 1143.37% for FY2024, 62859.0% down from the prior year.
  • EBIT Margin for Q4 2024 was 3453.95% at Spruce Biosciences, down from 1562.79% in the prior quarter.
  • The five-year high for EBIT Margin was 384.97% in Q4 2023, with the low at 3453.95% in Q4 2024.